Literature DB >> 28403989

Hepatitis C treatment and liver cancer recurrence: cause for concern?

Jose D Debes1, Harry L A Janssen2, Andre Boonstra3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28403989     DOI： 10.1016/S2468-1253(16)30204-7

Source DB:  PubMed          Journal:  Lancet Gastroenterol Hepatol


× No keyword cloud information.
  5 in total

1.  Pathway of care of hepatocellular carcinoma in 2017.

Authors:  Federica Invernizzi; Massimo Colombo
Journal:  Hepat Oncol       Date:  2017-06-21

Review 2.  Remaining clinical issues in hepatitis C treatment.

Authors:  Alexander Wong; Cynthia Tsien; Sarah Mansour; Curtis Cooper
Journal:  Can Liver J       Date:  2018-07-17

3.  Treatment of Real-World HCV Genotype 2-Infected Japanese Patients with Sofosbuvir plus Ribavirin.

Authors:  Tatsuo Kanda; Masato Nakamura; Shin Yasui; Yuki Haga; Akinobu Tawada; Eiichiro Suzuki; Yoshihiko Ooka; Koji Takahashi; Reina Sasaki; Shuang Wu; Shingo Nakamoto; Makoto Arai; Fumio Imazeki; Osamu Yokosuka
Journal:  Biology (Basel)       Date:  2017-05-09

4.  The hepatitis C viral nonstructural protein 5A stabilizes growth-regulatory human transcripts.

Authors:  Liang Guo; Suresh D Sharma; Jose D Debes; Daniel Beisang; Bernd Rattenbacher; Irina Vlasova-St Louis; Darin L Wiesner; Craig E Cameron; Paul R Bohjanen
Journal:  Nucleic Acids Res       Date:  2018-03-16       Impact factor: 16.971

Review 5.  Epidemiology and Elimination of HCV-Related Liver Disease.

Authors:  Pierre Pradat; Victor Virlogeux; Eric Trépo
Journal:  Viruses       Date:  2018-10-06       Impact factor: 5.048
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.